Endocytic pathways are highly dynamic gateways for molecules to enter cells. Functionality and specificity is in part controlled by a number of small GTPases called Rabs. In defined cellular locations, Rabs mediate multiple functions in membrane trafficking via their specific interaction with organelle membranes and a host of affector and effector molecules. On endocytic pathways, Rabs have been shown to control the formation of vesicles on the plasma membrane and the downstream delivery of internalized molecules to a number of cellular locations. As numerous Rabs are located to endocytic pathways, an internalized molecule may traverse a number of Rab specific substations or subdomains en route to its final destination. Rabs 5, 21 and 22 have all been localized to the early endocytic pathway and have been shown to share a number of characteristics to merit their segregation into a single functional endocytic group. In this review, we compare experiments that describe similarities and differences in endosome morphology and function that is mediated by their expression in cells.
alternatively, less well characterized mechanisms, such as macropinocytosis, clathrin-independent endocytosis and caveoleae [2] . Once internalized, these vesicles are thought to fuse with the first sorting endocytic station, which we define here as the early endosome, and this structure segregates molecules to distinct transport pathways.
The endocytic pathway along which a molecule traverses from entry to final destination will be mediated in part by one or several members of a family of small GTPases called Rabs [4] [5] [6] [7] . Rab proteins belong to the Ras superfamily of small GTPases that shuttle between GDP-and GTP-bound states to mediate their cellular effects. The GDP/GTP cycle is modulated by factors that catalyse nucleotide exchange and hydrolysis, and most Rabs alternate between membrane (active) and cytosolic (inactive) states. Shuttling is aided by the cytosolic Rab chaperones GDI (GDP-dissociation inhibitor) and REP (Rab-escort protein). Rabs control numerous cellular trafficking steps, and functional identity is characterized by their specific binding to distinct organelles on, for example, the secretory and endocytic pathways. Membrane attachment and further specificity is mediated by their post-translational modification via C-terminal geranylgeranylation [8] .
Today, the full sequences of hundreds of Rabs from different species are known, including the 60 or so variants that are found in the human genome. A number of these have been studied, although few extensively so, and a general emerging theme is that, via interaction with a multitude of affector and effector molecules, they control several cellular functions, including some outside the classical remit of organization of membrane traffic and dynamics.
In distinct membrane locations, Rabs orchestrate organelle biogenesis and fusion, and directed transport of vesicles along cytoskeletal frameworks, and there is increasing evidence of a defined link with cell signalling pathways [9, 10] .
Rab definition and specificity
Rabs, as members of the Ras superfamily of GTPases have highly conserved motifs that mediate binding to the nucleotide. Studies in Ras have identified specific point mutations that generated proteins that are either predominantly bound to GDP or that have very low GAP (GTPase-activating protein)-stimulated GTPase activity [11, 12] . Based on their effects in cells, these are often described as dominant-negative and constitutively active, and also GDP-binding and GTP-hydrolysis mutants. For Rab proteins, mutation of a conserved Ser/Thr→Asn in the phosphate/magnesium-binding PM1 motif (e.g. Rab5a residue 34) or Asn/Thr→Ile mutation in a separate nucleotidebinding G2 motif (Rab5 residue 133) leads to a GDP-binding mutant. Conversely, mutation of a Gln/Thr→Leu in another distinct PM3 motif (e.g. Rab5a residue 79) generates a GTP-hydrolysis mutant [13] . The ability to express such Rab mutants in cells or purify them prior to their addition to membrane transport assays has been the main tool for studying the function of these proteins. Silencing Rab expression via RNAi (RNA interference) technology is also now gaining widespread importance.
Endocytic Rab proteins
As secretory, endocytic and recycling pathways are inexorably linked, it is sometimes difficult to assign proteins such as Rabs to just one of these. However, at least 13 Rab family members are now known to be involved in the dynamics of the endocytic pathway, and information on the majority of these was described by Somsel Rodman and Wandinger-Ness in 2000 [14] . Roles are described for Rab5 in early endosome dynamics, Rab7 as being a mediator of late endocytic traffic, and functions for Rabs 4 and 11 in recycling to the plasma membrane. Several endocytic Rabs have now been pinpointed to early endosomes, and an intriguing question is how so many Rabs, some of which have been postulated to co-inhabit single endosomes, relate to each other both temporally and functionally. Phylogenic scrutiny of Rabs suggests they can in fact be segregated into distinct functional groups, and one of these, group V, was specific for Rabs 5, 21 and 22 [5] . Rab5 has been studied extensively, but comparatively little information is available for Rab21 and 22. The present review will focus on these three variants and recent data that suggest common traits and unique features between them.
Extensive phylogenic analysis of Rabs from different species have identified Rab-specific motifs which were numbered RabF1-5 [5, 15, 16] . Further scrutiny of Rab sequences have also allowed for classification of Rabs into subfamilies that are homologous in sequences called specificity determining regions (RabSF). RabSF domains 1-4 are conserved across species, and are predicted to mediate binding of Rabs to specific effector proteins. These domains are often associated within the more commonly identified switch I and switch II domains, defined initially from Ras structure-activity studies. Thus Rabs belonging to the same subfamily would be predicted to share common interacting proteins. The emerging picture was that general Rab-binding proteins, such as GDI and REP, would bind to RabF regions and Rab specificity would be mediated via interactions with RabSF domains. Thus new criteria for Rab isoforms should include conservation of sequence and RabF domains, but also of RabSF domains. One RabSF motif is in the hypervariable C-terminal region, which is classically the largest differentiating denominator between individual Rabs. When sequences from Rabs from different species were compared using these parameters with the functional data on Rabs from different species, there appeared to be functional segregation-phylogeny of function. This approach segregated some Rabs into functional groups that contained members previously shown to be dissimilar in localization and function. For example, group II contains Rab2, Rab4 and Rab11 and thus it remains to be seen what common functional characteristic is actually shared by these members. As mentioned above, functional group V was exclusive for human Rab5a, b and c, Rab22a, b and c, and Rab21, together with their isoforms in other species.
Comparison of endosome morphologies in cells expressing Rabs5, 21 and 22
Isoforms have been identified for Rabs 5 and 22, but to date only one for Rab21 (Table 1 ). Rab5 isoforms are highly homologous, but the individual variants are only 40-50% similar (Table 1) .
Rab5 is one of the most studied Rab proteins and is localized to the plasma membrane, clathrin-coated vesicles, sorting endosomes and phagosomes [7] . The majority of work on Rab5 has been performed with the 5a isoform and, unless specified, Rab5 in the present review refers to Rab5a. The three Rab5 variants colocalize on early endosomes, and their overexpression in transfected cells leads to the formation of slightly enlarged transferrin-receptor-positive structures [17, 18] . These organelles are even larger when the corresponding GTPase-defective mutants are expressed [18, 19] . Thus, in unstimulated cells, there does not appear to be any obvious morphological difference in endosomes of cells overexpressing Rab5a, b or c. However, when cells are stimulated with EGF (epidermal growth factor), then only cells expressing wild-type Rab5a have swollen vacuoles akin to those observed in Rab5a Gln 79 →Leu-expressing cells [20] . The functional significance of these findings with respect to the three isoforms is discussed below.
GFP (green fluorescent protein)-Rab22a labels the plasma membrane and early endosomes, and overexpression of the wild-type variant leads to the formation of very swollen vacuole-like structures that also harbour EEA1 (early endosome antigen 1), Rab5 and internalized probes [21, 22] . In one study, the distribution pattern was cell-line-dependent, and, in HeLa cells, a significant fraction of the Rab22a protein also co-localized with Golgi markers [22] . Earlier reports suggested that Rab22a distribution was not cell-type-dependent [21] , and, in the present study, a fraction of Rab22a was localized to late endosomes. Both of these reports indicate that the morphological effects of Rab22a expression are more pronounced than those of Rab5, and the Rab22a phenotype was more akin to that observed in cells expressing Rab5 Gln 79 →Leu. More recent data challenges these findings, showing specifically that endogenous Rab22a localizes to tubules that emanate from a perinuclear area and are involved in recycling of MHCI (major histocompatibility complex class I) from endosomes to the plasma membrane [23] . As an anti-Rab22 antibody was not utilized in the former two studies, it was suggested that the observed swelling phenotypes were due to gross overexpression [23] . Rat Rab22b (rRab22b) shares 94% iden- tity with human Rab22b, and, in HeLa cells, the YFP (yellow fluorescent protein)-tagged protein associates with large swollen asymmetrical structures close to the nucleus that seemed to bud tubular Rab22b-positive processes that extended towards the cell periphery [24] . Human Rab22a Gln 64 →Leu was also found associated with lysosomal markers, suggesting that the mutation results in enhanced endosome fusion similar to those observed in cells expressing Rab5 Gln 79 →Leu, and that these structures may be akin to the previously described Rab5 Gln 79 →Leu early-late hybrid organelles [25, 26] . In the case of Rab21, an anti-Rab21 antibody revealed that the subcellular distribution of this protein was dependent on cell polarity with endoplasmicreticulum-like staining in non-polarized cells and apical (possibly late endosomal) distribution in polarized cells [27] . Since this report, Rab21 has been thought to be specific for polarized cells, despite the fact that it was shown to be expressed ubiquitously [27] . Using fluorescence and electron microscopy, we have shown that GFP-Rab21 localizes to the perinuclear region, on distinct peripheral vesicles and occasionally on the plasma membrane ( Figure 1 , and [28] ). Co-localization with markers for subcellular organelles identified the perinuclear labelling as Golgi and the vesicular structures as early endosomes. Comparison with the distribution of the early endosomal marker and Rab5 effector, EEA1, demonstrated that, in overexpressing cells, Rab21 localized to enlarged endosmes. The findings were confirmed using a previously characterized Rab21 antibody [27] and were supported further by co-localization of Rab21 with probes internalized to specifically label early endosomes (transferrin and EGF). Surprisingly, in Rab21 Gln 78 →Leu-expressing cells, EEA1-labelled endosomes have normal morphologies, but gain the additional presence of an extensive reticular tubular network that has yet to be fully characterized. The expression of the GDP-binding-defective mutants again revealed major differences between the three variants. Rab5a Ser 34 →Asn-and Asn 133 →Ile-expressing cells typically have small endosomes; vesiculotubular structures have also been described [17] . As expected, a much larger fraction of the Rab GDP-binding mutants is cytosolic. The phenotypes of cells expressing the GDP-binding-and GTP-hydrolysis-defective mutants parallel their effects in in vitro assays of early endosome fusion, which is stimulated and inhibited by Rab5 Gln 79 →Leu and Rab5 Asn 133 →Ile respectively [17, 29] . There were no major morphological differences between cells expressing mutants of all three Rab5 isoforms and they behaved similarly in stimulating and inhibiting endosome-fusion assays [18] . Rab22a Ser 19 →Asn labelling is also cytosolic [21] [22] [23] , but the protein is additionally found associated with the Golgi apparatus, and this phenomenon was also been seen when the equivalent rRab22b mutation was expressed [24] . Surprisingly, and in contrast with the effects of the wildtype and GTP-hydrolysis mutants, Rab22a Ser 19 →Asn expression did not significantly affect the morphologies of EEA1-labelled endosomes [22] . Rab21 Thr 33 →Asn labels intensely in a juxta-nuclear region (Figure 1 ), co-localizing with TGN (trans-Golgi network) markers [28] . The significance of this Golgi localization for GDP-binding mutants of Rabs 21 and 22 is unknown, and although their expression does not significantly impair TGN morphology, a role for rRab22b in TGN-endosome traffic was postulated [24] . Addition of Rab21 and 22 variants to endosome fusion and Golgi-endosome transport assays will undoubtedly shed further insight into their cellular roles.
Co-localization of endocytic Rab proteins
Co-transfection of cells with Rabs 4, 5 and 11 was performed to compare the number of endocytic structures that contained more than one Rab and to analyse the temporal nature of the transferrin cycle with respect to co-localization of the ligand with these endocytic Rabs [30] . Transferrin was initially located in Rab5-positive compartments and then traversed Rab4 and Rab11 vesicles, as predicted. It was postulated from these studies that the transit of transferrin was not necessarily through Rab-specific endosomes, but rather through Rab domains on the same endosome [7] . To analyse further the distribution of Rabs on endosomes, Rab21 was co-expressed with Rabs previously localized to the secretory pathway and to early, late and recycling endosomes. Extensive (Ͼ75%) overlap of Rab21 was observed with a specific subset of Rabs, including Rab4, Rab5a and Rab22a (Figure 1) , and also Rab17, an endo-cytic variant that is predominantly expressed in epithelial cells [31] . Interestingly, Rab17 is closely homologous with Rabs 5, 21 and 22 in the functional prediction model [5] . It therefore seems likely that a single endosome could contain several Rab variants, and that each is involved with mediating specific transport steps from and to this organelle. As most Rabs are ubiquitously expressed, a major challenge remains in defining their relationship to each other, their host organelle and the cargo they help deliver.
Endocytic function in cells expressing mutants of Rab5, Rab21 and Rab22
The initial characterization of Rab5 was based on its subcellular localization and the effects of the mutants on in vitro assays of early endosome fusion and on functional uptake experiments in cells [18, 19, 29] . In general, expression of the wild-type and Gln 79 →Leu Rab5a protein had stimulatory effects, but the expression of the GTP-binding mutant was inhibitory to these assays. Endocytic pathways are extensively linked to signalling events at the plasma membrane [9, 10, [32] [33] [34] , and insights on differential roles for Rab5 isoforms have come from experiments investigating the mechanism by which the dynamics of endocytic pathways are modified after cell stimulation with EGF [20] . Expression of the three Rab5 isoforms enhanced fluid-phase uptake in unstimulated cells, but only the Rab5a isoform promoted endocytosis further in response to EGF. Expression of Rab5a also had much more pronounced effects on EGF uptake compared with Rab5b and Rab5c. In contrast, earlier studies showed comparable abilities of the three isoforms to enhance transferrin uptake from the plasma membrane [18] . As the three Rab5 isoforms share Ͼ80% homology (Table 1) , it should not be difficult to identify the domain(s) responsible for these EGF-specific effects. It also remains to be seen whether this is a phenomenon observed with other growth factors and whether expression of the GTP-binding-defective mutants of the three isoforms have different effects on EGF-stimulated endocytosis.
Several of these studies on the effects of Rab5 expression on EGF internalization and, to a certain extent, a role for Rab5 in the formation of clathrin-coated vesicles [35] at the plasma membrane were challenged recently [36] . HeLa and HepG2 cells overexpressing wild-type Rab5 and Rab5 mutants were found to have control levels of internalized EGF, and the effects of Rab5 Ser 34 →Asn on EGF traffic were determined to be downstream of the plasma membrane. Additionally, Rab5 expression had no effect on uptake of a fluidphase marker. There are other reports on the lack of Rab5 Ser 34 →Asn effect or a very minor effect on uptake of receptors predicted to be internalized via clathrin-coated vesicles, including EGF [37, 38] . In Saccharomyces cerevisiae, loss of function of one or a combination of the Rab5 homologues Ypt51, 52 and 53 (Ypt is yeast protein transport) was without effect on internalization of ␣-factor, but loss of Ypt51 led to significant reduction in ␣-factor degradation; trafficking abnormalities away from the plasma membrane were also reported for the other variants [39, 40] . These data are supported by RNAi analysis showing no effect on uptake of transferrin or EGF after silencing expression,
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individually, of Rab5a, b and c [41] . It remains to be seen how these findings relate to the extensive literature showing that expression of Rab5 Ser 34 →Asn significantly inhibits the uptake of several unrelated molecules and pathogens. Cell type and expression levels are undoubtedly important parameters. Numerous endocytic defects have been attributed to overexpression or loss of function of Rab22a. These range from an ability of Rab22a and Rab22a Gln 64 →Leu to partially inhibit degradation of EGF to a reduction of fluidphase endocytosis in cells expressing Rab22a and Rab22a Ser 19 →Asn [21, 22] . Expression of Rab22a and the nucleotide-binding mutants inhibited the recycling of MHCI to varying degrees, whereas only the Ser 19 →Asn mutant significantly reduced formation of MHCI tubules [23] . These data were supported by silencing Rab22a expression, leading to a 75% reduction in recycling of MHCI and a minor inhibition in recycling of transferrin. It will be interesting to see whether silencing Rab22 also inhibits EGF degradation and fluid-phase uptake, as this would suggest that Rab22 is required for the general integrity of different endocytic pathways.
No defects in endocytosis were observed in cells expressing Rab21 or Rab21 Gln 78 →Leu; however, both uptake of EGF and transferrin are reduced in cells expressing Rab21 Thr 33 →Asn and there is also a traffic defect in EGF delivery to late endosomes and lysosomes [28] . EGF degradation has therefore been shown to be inhibited to various extents in cells overexpressing, predominantly, the GDP-binding mutant of Rabs 4, 5, 7, 21 and 22 [22, 42] . Since internalized ligands, such as EGF, move through different Rab stations or domains, all of these studies highlight the fact that common Rab-interacting partners may be sequestered via overexpression of one variant. Moreover, endocytic pathways and organelles for transferrin, EGF and MHCI traffic are linked, such that loss of function of one pathway may lead to the partial or complete failure of another. Thus an observed inhibition in a given trafficking step due to overexpression of a Rab does not necessarily relate to an absolute requirement for the protein in that pathway. If Rabs are indeed membrane organizers, then the same may be true when one Rab is silenced using RNAi.
Mice knockouts of Rabs5, 21 or 22 genes have not been described, but, interestingly, RNAi feeding experiments in Caenorhabditis elegans revealed that Rab21 inhibition was without a phenotype, whereas the Rab5 was larval lethal ( [43] and http://www.wormbase.org/); Rab22 is not expressed in this organism.
Rab-interacting proteins
Functional specificity and activity of Rabs are mediated by their affectors and effectors located both in the cytosol and on membranes. New Rab5 affectors and effectors appear in the literature with striking consistency, and each new partner expands the complexity of the involvement of this protein with endocytic and, more recently, signalling and cytoskeletal processes [7, 10, 44, 45] . Indeed, over 20 Rab5-GTP interacting partners were initially described from an affinity screen, and many of these await characterization [46] . These are soluble proteins and there is comparatively very little information regarding the interaction of endocytic Rabs, or indeed other Rabs, with integral membrane components.
Should each Rab have 20 soluble interacting partners, then approx. 5% of the human genome would be preoccupied with Rab protein function! But, as described above, the RabF and RabSF domains add two levels of similarity that ensure that proteins, such as GDI and REP, probably bind to all Rabs; Rab effectors themselves, though to a lesser degree, are now known to be promiscuous. Rabaptin-5 and Rabenosyn-5 bind to Rab4 [47, 48] , and, interestingly, the affinity-column approach used to identify Rab5-binding partners also showed that Rab33b had a direct or indirect interaction with these two proteins [49] . Rab33b was initially localized and proposed to function in the medial Golgi [49, 50] .
It is predicted that Rabs5, 21 and 22 will share many binding partners, but as research on the latter two variants is in its infancy, this remains to be tested. Rab22a has, however, been shown to interact with EEA1, but the interaction seems to be slightly different to that of Rab5 with this protein [22] . As Rab21 is also capable of enlarging early endosomal membranes, it is postulated that Rab21 and EEA1 interaction mediates this phenomenon, suggesting that all three Rab variants promote endosomal swelling via a common fusion mechanism. The phenotypes of the GDP-binding and GTP-hydrolysis mutants of Rab21, however, suggest major differences between their capacity to control endosomal traffic. The challenge now is to identify unique interacting proteins and trafficking pathways.
